3186 results for «502»

Filter By

3186 results

Challenging TAVI scenarios

14 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session is for you if you want to learn more about recurrent valve migration during TAVR or TAVI with permanent pacemaker implantation, among others!

Challenging TAVI scenarios

Challenging CTO cases - Session 2

14 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session compiles 5 challenging CTO cases and explains how to handle them. Study for example a flush ostial RCA-CTO, PWS in a CTO feeding vessel, rotablation and intravascular lithotripsy in three-vessel disease with IVUS, or rotaburr incarceration.

Challenging CTO cases - Session 2

The why and how of performing a successful TAVI case

14 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, observe a 72-year-old male patient with NYHA class II exertional dyspnoea, CAD status after revascularisation, type II DM, CKD IIIB, recently admitted for decompensated HF and type II NSTEMI, who was referred to the clinic for aortic valve replacement.

The why and how of performing a successful TAVI case

Challenging ACS scenarios

14 Dec 2022 – From GulfPCR-GIM 2022

Topics in this GulfPCR-GIM 2022 session include the role of imaging in an unusual case of ACS in a young patient, PCI of an abnormal left coronary artery with AMI, embolisation of a thrombus in a non-culprit vessel during PCI in a late-presenting anterior STEMI, and...

Challenging ACS scenarios

PCI in stable CAD

14 Dec 2022 – From GulfPCR-GIM 2022

Study the two cases presented in this GulfPCR-GIM 2022 session to find out more about the importance of proper monitoring in detecting post-PCI complications and managing complex PCI and coronary stent loss.

PCI in stable CAD

ISCHEMIA-CKD EXTEND: revascularization does not improve outcomes at 5 years in patients with advanced chronic kidney disease

29 Aug 2022

Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results - clinical outcomes at 5 years of follow-up, which were presented during the ESC 2022 congress in Barcelona.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
ISCHEMIA-CKD EXTEND - Clinical Outcomes at 5 years of Follow-up
Didn’t find what you were looking for?